Fei Luo
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Genetics top 2%
- Mesenchymal stem cell research
Papers in
-
- Bone Metabolism and Diseases 21
- Circular RNAs in diseases 12
- Extracellular vesicles in disease 10
-
- MicroRNA in disease regulation 20
- Co-authors
- Jianzhong Xu (52 shared papers)Tianyong Hou (35 shared papers)Ce Dou (32 shared papers)Qizhan Liu (15 shared papers)Shiwu Dong (27 shared papers)Zhao Xie (23 shared papers)Junchao Xue (10 shared papers)Hui Xu (10 shared papers)
- Journals
- Tissue Engineering Part A (6 papers)Cell Death and Disease (4 papers)Toxicology and Applied Pharmacology (4 papers)International Orthopaedics (3 papers)Advanced Science (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Fei Luo
131 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 134
- Cancer Research 1.1k
- Genetics 380
- Molecular Biology 2.1k
- Orthopedics and Sports Medicine 149
- Urology 102
Countries citing papers authored by Fei Luo
This map shows the geographic impact of Fei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Luo more than expected).
Fields of papers citing papers by Fei Luo
This network shows the impact of papers produced by Fei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Luo. The network helps show where Fei Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 247 | |
| 2 | 2008 | 203 | |
| 3 | 2018 | 162 | |
| 4 | 2016 | 161 | |
| 5 | 2018 | 155 | |
| 6 | 2017 | 137 | |
| 7 | 2016 | 101 | |
| 8 | 2021 | 80 | |
| 9 | 2019 | 80 | |
| 10 | 2009 | 75 | |
| 11 | 2021 | 72 | |
| 12 | 2021 | 72 | |
| 13 | 2017 | 70 | |
| 14 | 2013 | 67 | |
| 15 | 2018 | 65 | |
| 16 | 2012 | 65 | |
| 17 | 2021 | 58 | |
| 18 | 2020 | 57 | |
| 19 | 2018 | 56 | |
| 20 | 2014 | 55 |
About Fei Luo
Fei Luo is a scholar working on Molecular Biology, Cancer Research, Surgery, Immunology and Oncology, having authored 138 papers that have together received 4.0k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (21 papers), MicroRNA in disease regulation (20 papers), Bone Tissue Engineering Materials (15 papers), Circular RNAs in diseases (12 papers), Extracellular vesicles in disease (10 papers), Orthopedic Infections and Treatments (9 papers), Bone fractures and treatments (8 papers) and Mesenchymal stem cell research (8 papers). The work is most often cited by research in Cancer Research (1.1k citations), Genetics (380 citations), Molecular Biology (2.1k citations), Orthopedics and Sports Medicine (149 citations) and Urology (102 citations). Fei Luo has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jianzhong Xu, Tianyong Hou, Ce Dou, Qizhan Liu, Shiwu Dong, Zhao Xie, Junchao Xue, Hui Xu, Xinlu Liu and Qinyu Ma. Their work appears in journals such as Tissue Engineering Part A, Cell Death and Disease, Toxicology and Applied Pharmacology, International Orthopaedics and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.